Children who are the youngest in their class to be identified with ADHD are just as likely to keep the diagnosis as older pupils in their year group, scientists have found.
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab – Pharmaceutical Technology
Biopharmaceuticals company AbbVie have pulled out of their deal with I-Mab. Photo: Valeriya Zankovych / Shutterstock.com. Biopharma giant AbbVie has announced it intends to terminate